Recent Updates
Recently added Catalysts

Arctic Sun cooling device, Standard of Care

Phase 1

Intracerebral Hemorrhage | Unknown | Neurology |Community Health Systems, Inc.|Last Updated: Jan 10, 2017

Success Probability

Subscribe to view

Market & Valuation

Subscribe to view

Trial Design

RandomizedACTIVE_CONTROLLED
Total Trials1
Total Enrollment9

FDA Designations

No designations recorded

Clinical trial landscape

Arctic Sun cooling device, Standard of Care · 1 trial · 1 indication

Early Phase 1 1
NCT02078037Systemic Normothermia in Intracerebral Hemorrhage (ICH)Intracerebral Hemorrhage
COMPLETED9 Analytics
EARLY_PHASE1COMPLETED
Systemic Normothermia in Intracerebral Hemorrhage (ICH)
Intracerebral HemorrhageUnlock trial analytics

Study Endpoints

Primary Endpoints

MRI measurement of relative perihematomal edema (% change of perihematomal edema)
First 5 days of hospital course

Percent relative perihematomal edema growth between the initial MRI and the 5 day MRI

Secondary Endpoints

Structured telephone interview of functional and cognitive outcome
3 months and 1 year
Serum cytokine measurement with inflammatory cytokine protein array
5 days
Unlock Study Endpoints

Study Design & Arms

AllocationRANDOMIZED
MaskingSINGLE
ModelPARALLEL
PurposeTREATMENT

Treatment Arms

ArmTypeDescription
Arctic Sun cooling deviceEXPERIMENTALThe Arctic Sun device pads will be placed on the patient as per manufacturer's instructions. Patients, who cannot tolerate placement of all the pads for any given reason, will still be included in the study if they can maintain normothermia (normal body temperature). The total normothermia time for the study is five days. After 5 days, the attending physician will make clinical decisions based on the patient needs.The temperature goal for this study is 36.5 degree Celsius, but normothermia for the purpose of this study will be defined as a temperature of 35.5 - 37.5 degree Celsius. A thermometer mounted urinary catheter will be used for temperature monitoring and feedback to the Arctic Sun.
Standard of CareACTIVE_COMPARATORPatient will be given standard fever management (acetaminophen + cooling blanket at the discretion of the treating physician) initiated at a temperature of 38.5 degrees Celsius

Interventions

NameTypeDescription
Arctic Sun cooling deviceDEVICEThe Arctic Sun® 5000 Temperature management systems (Bard Medical), a non- invasive, surface cooling technology that allows rapid and precise manipulation of core body temperature will be employed to maintain normothermia (normal temperature) in patients with ICH randomized to the treatment group.
Standard of CareOTHERPatient will be given standard fever management (acetaminophen + cooling blanket at the discretion of the treating physician)
Unlock Study Design Details

Eligibility Criteria

Age Range18 Years to 85 Years
SexALL
Healthy VolunteersNo
Study Sites1

Inclusion Criteria: 1. Patients with spontaneous supratentorial ICH \>20 cc 2. Age 18 to 85 years of age 3. Consent from the patient or surrogate decision maker 4. Within 24 hours of onset of ictus Exclusion Criteria: 1. Hemorrhage secondary to trauma, Arterio-venous malformation (AVM), aneurysm ...

Countries:United States
Unlock Eligibility Criteria